CD8A and myeloid sarcoma: Immune senescence may compromise antiviral immune responses,20,21 and aging among MS patients under DMT is associated with an increased risk of infection.22 Indeed, aging affects both CD4+ and CD8+ T lymphocytes, crucial for JCV control, by altering their functionality but also by decreasing the number of naive T cells.